Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFR^WT and EGFR^T790M inhibitors

References

• Taher RF, Al-Karmalawy AA, Abd El Maksoud AI, Khalil H, Hassan A, El-Khrisy E-DA, El-Kashak W. Two new flavonoids and anticancer activity of Hymenosporum flavum: in vitro and molecular docking studies. J Herbmed Pharmacol. 2021;10(4):443–458.
   Google Scholar
• Ghanem A, Al-Karmalawy AA, Abd El Maksoud AI, Hanafy SM, Emara HA, Saleh RM, Elshal MF. Rumex Vesicarius L. extract improves the efficacy of doxorubicin in triple-negative breast cancer through inhibiting Bcl2, mTOR, JNK1 and augmenting p21 expression. Inf Med Unlocked. 2022; 29:100869.
   Google Scholar
• Diab RT, Abdel-Sami ZK, Abdel-Aal EH, Al-Karmalawy AA, Abo-Dya NE. Design and synthesis of a new series of 3,5-disubstituted-1,2,4-oxadiazoles as potential colchicine binding site inhibitors: antiproliferative activity, molecular docking, and SAR studies. New J Chem. 2021;45(46):21657–21669.
   Web of Science ®Google Scholar
• Reda R, Al-Karmalawy AA, Alotaibi M, Saleh M. Quinoxaline derivatives as a promising scaffold for breast cancer treatment. New J Chem. 2022;46:9975–9984.
   Web of Science ®Google Scholar
• Khalifa MM, Al-Karmalawy AA, Elkaeed EB, Nafie MS, Tantawy MA, Eissa IH, Mahdy HA. Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies. J Enzyme Inhib Med Chem. 2022;37(1):299–314.
   PubMed Web of Science ®Google Scholar
• Al-Warhi T, Elbadawi MM, Bonardi A, Nocentini A, Al-Karmalawy AA, Aljaeed N, Alotaibi OJ, Abdel-Aziz HA, Supuran CT, Eldehna WM. Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII. J Enzyme Inhib Med Chem. 2022;37(1):2635–2643.
   PubMed Web of Science ®Google Scholar
• Christie E, Bowtell D. Acquired chemotherapy resistance in ovarian cancer. Ann Oncol. 2017;28(8):viii13–viii15.
   PubMedGoogle Scholar
• Demaria M, O’Leary MN, Chang J, Shao L, Liu S, Alimirah F, Koenig K, Le C, Mitin N, Deal AM, et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 2017;7(2):165–176.
   PubMed Web of Science ®Google Scholar
• Munikrishnappa CS, Suresh Kumar GV, Bhandare RR, Konidala SK, Sigalapalli DK, Vaishnav Y, Chinnam S, Yasin H, Al-Karmalawy AA, Shaik AB. Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agents. J Saudi Chem Soc. 2022;26(3):101447.
   Web of Science ®Google Scholar
• Hammoud MM, Nageeb AS, Morsi MA, Gomaa EA, Abo Elmaaty A, Al-Karmalawy AA. Design, synthesis, biological evaluation, and SAR studies of novel cyclopentaquinoline derivatives as DNA intercalators, topoisomerase II inhibitors, and apoptotic inducers. New J Chem. 2022;46(23):11422–11436.
   Web of Science ®Google Scholar
• El-Helby AGA, Sakr H, Eissa IH, Abulkhair H, Al-Karmalawy AA, El-Adl KJAP. Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR-2 inhibitors. Arch Pharm Chem Life Sci. 2019;352(10):1900113.
   Web of Science ®Google Scholar
• El-Helby AGA, Sakr H, Eissa IH, Al-Karmalawy AA, El-Adl K. Benzoxazole/benzothiazole-derived VEGFR-2 inhibitors: design, synthesis, molecular docking, and anticancer evaluations. Arch Pharm Chem Life Sci. 2019;352(12):1900178.
   Web of Science ®Google Scholar
• Huang M, Shen A, Ding J, Geng M. Molecularly targeted cancer therapy: some lessons from the past decade. Trends Pharmacol Sci. 2014;35(1):41–50.
   PubMed Web of Science ®Google Scholar
• El-Shershaby MH, Ghiaty A, Bayoumi AH, Al-Karmalawy AA, Husseiny EM, El-Zoghbi MS, Abulkhair HS. From triazolophthalazines to triazoloquinazolines: a bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity. Bioorg Med Chem. 2021;42:116266.
   PubMed Web of Science ®Google Scholar
• Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 2000;19(13):3159–3167.
   PubMed Web of Science ®Google Scholar
• Zaki AA, Al-Karmalawy AA, Khodir AE, El-Amier YA, Ashour A. Isolation of cytotoxic active compounds from Reichardia tingitana with investigation of apoptosis mechanistic induction: in silico, in vitro, and SAR studies. S Afr J Bot. 2022;144:115–123.
   Web of Science ®Google Scholar
• Elmaaty AA, Darwish KM, Chrouda A, Boseila AA, Tantawy MA, Elhady SS, Shaik AB, Mustafa M, Al-Karmalawy AA. In silico and in vitro studies for benzimidazole anthelmintics repurposing as VEGFR-2 antagonists: novel mebendazole-loaded mixed micelles with enhanced dissolution and anticancer activity. ACS Omega. 2022;7(1):875–899.
   PubMed Web of Science ®Google Scholar
• El-Naggar AM, Hassan AMA, Elkaeed EB, Alesawy MSA, Karmalawy AA. Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2. Bioorg Chem. 2022;123:105770.
   PubMed Web of Science ®Google Scholar
• Fuchs-Tarlovsky V. Role of antioxidants in cancer therapy. Nutrition. 2013;29(1):15–21.
   PubMed Web of Science ®Google Scholar
• Yang Z, Qi Y, Lai N, Zhang J, Chen Z, Liu M, Zhang W, Luo R, Kang S. The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018;37(1):1–10.
   PubMedGoogle Scholar
• Mohareb R, Fahmy S. Reaction of malononitrile and ethyl cyanoacetate: a novel synthesis of polyfunctional pyridine derivatives. Zeitschrif Naturforschung B. 1985;40(11):1537–1540.
   Google Scholar
• Khalaf H, Tolan H, El-Bayaa M, Radwan M, El-Manawaty M, El-Sayed W. Synthesis and anticancer activity of new pyridine-thiophene and pyridine-furan hybrid compounds, their sugar hydrazone, and glycosyl derivatives. Russ J Gen Chem. 2020;90(9):1706–1715.
   Web of Science ®Google Scholar
• Sharma V, Chitranshi N, Agarwal AK. Significance and biological importance of pyrimidine in the microbial world. Int J Med Chem. 2014;2014:202784.
   PubMedGoogle Scholar
• Maddila S, Gorle S, Seshadri N, Lavanya P, Jonnalagadda SB. Synthesis, antibacterial and antifungal activity of novel benzothiazole pyrimidine derivatives. Arabian J Chem . 2016;9(5):681–687.
   Web of Science ®Google Scholar
• El-Sharkawy KA, AlBratty MM, Alhazmi HA. Synthesis of some novel pyrimidine, thiophene, coumarin, pyridine and pyrrole derivatives and their biological evaluation as analgesic, antipyretic and anti-inflammatory agents. Braz J Pharm Sci. 2018;54(4).
   Web of Science ®Google Scholar
• De Luca M, Ioele G, Ragno G. 1, 4-Dihydropyridine antihypertensive drugs: Recent advances in photostabilization strategies. Pharmaceutics. 2019;11(2):85.
   PubMed Web of Science ®Google Scholar
• Kaminski K, Obniska J, Zagorska A, Maciag D. Synthesis, physicochemical and anticonvulsant properties of new N-(pyridine-2-yl) derivatives of 2-azaspiro [4.4] nonane and [4.5] decane-1, 3-dione. Part II. Arch Pharm (Weinheim). 2006;339(5):255–261.
   PubMed Web of Science ®Google Scholar
• Wang N, Yang Q, Deng Z, Mao X, Peng Y. Rhodium-catalyzed merging of 2-arylquinazolinone and 2, 2-difluorovinyl tosylate: diverse synthesis of monofluoroolefin quinazolinone derivatives. ACS Omega. 2020;5(24):14635–14644.
   PubMed Web of Science ®Google Scholar
• Kumar S, Narasimhan B. Therapeutic potential of heterocyclic pyrimidine scaffolds. Chem Cent J. 2018;12(1):1–29.
   PubMedGoogle Scholar
• Lee HW, Kim BY, Ahn JB, Kang SK, Lee JH, Shin JS, Ahn SK, Lee SJ, Yoon SS. Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione. Eur J Med Chem. 2005;40(9):862–874.
   PubMed Web of Science ®Google Scholar
• Davari AS, Abnous K, Mehri S, Ghandadi M, Hadizadeh F. Synthesis and biological evaluation of novel pyridine derivatives as potential anticancer agents and phosphodiesterase-3 inhibitors. Bioorg Chem. 2014;57:83–89.
   PubMed Web of Science ®Google Scholar
• Prachayasittikul S, Pingaew R, Worachartcheewan A, Sinthupoom N, Prachayasittikul V, Ruchirawat S, Prachayasittikul V. Roles of pyridine and pyrimidine derivatives as privileged scaffolds in anticancer agents. Mini Rev Med Chem. 2017;17(10):869–901.
   PubMed Web of Science ®Google Scholar
• Wang J, Wu H, Song G, Yang D, Huang J, Yao X, Qin H, Chen Z, Xu Z, Xu C. A novel imidazopyridine derivative exerts anticancer activity by inducing mitochondrial pathway-mediated apoptosis. Biomed Res Int. 2020;2020:4929053.
   PubMed Web of Science ®Google Scholar
• Abdelaziz ME, El-Miligy MM, Fahmy SM, Mahran MA, Hazzaa AA. Design, synthesis and docking study of pyridine and thieno [2, 3-b] pyridine derivatives as anticancer PIM-1 kinase inhibitors. Bioorg Chem. 2018;80:674–692.
   PubMed Web of Science ®Google Scholar
• Abouzid KA, Al-Ansary GH, El-Naggar AM. Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities. Eur J Med Chem. 2017;134:357–365.
   PubMed Web of Science ®Google Scholar
• Cheney IW, Yan S, Appleby T, Walker H, Vo T, Yao N, Hamatake R, Hong Z, Wu JZ. Identification and structure–activity relationships of substituted pyridones as inhibitors of Pim-1 kinase. Bioorg Med Chem Lett. 2007;17(6):1679–1683.
   PubMed Web of Science ®Google Scholar
• Hamajima T, Takahashi F, Kato K, Mukoyoshi K, Yoshihara K, Yamaki S, Sugano Y, Moritomo A, Yamagami K, Yokoo K, et al. Discovery and biological evaluation of novel pyrazolopyridine derivatives as potent and orally available PI3Kδ inhibitors. Bioorg Med Chem. 2018;26(9):2410–2419.
   PubMed Web of Science ®Google Scholar
• Ibrahim DA, Ismail NS. Design, synthesis and biological study of novel pyrido [2, 3-d] pyrimidine as anti-proliferative CDK2 inhibitors. Eur J Med Chem. 2011;46(12):5825–5832.
   PubMed Web of Science ®Google Scholar
• Orlikova B, Chaouni W, Schumacher M, Aadil M, Diederich M, Kirsch G. Synthesis and bioactivity of novel amino-pyrazolopyridines. Eur J Med Chem. 2014;85:450–457.
   PubMed Web of Science ®Google Scholar
• Radwan MA, Alshubramy MA, Abdel-Motaal M, Hemdan BA, El-Kady DS. Synthesis, molecular docking and antimicrobial activity of new fused pyrimidine and pyridine derivatives. Bioorg Chem. 2020; 96:103516.
   PubMed Web of Science ®Google Scholar
• Elia SG, Al-Karmalawy AA, Nasr MY, Elshal MF. Loperamide potentiates doxorubicin sensitivity in triple-negative breast cancer cells by targeting MDR1 and JNK and suppressing mTOR and Bcl-2: In vitro and molecular docking study. J Biochem Mol Tox. 2022;36(1):e22938.
   PubMed Web of Science ®Google Scholar
• El-Azab MF, Al-Karmalawy AA, Antar SA, Hanna PA, Tawfik KM, Hazem RM. A novel role of Nano selenium and sildenafil on streptozotocin-induced diabetic nephropathy in rats by modulation of inflammatory, oxidative, and apoptotic pathways. Life Sci. 2022;303:120691.
   PubMed Web of Science ®Google Scholar
• Sigismund S, Avanzato D, Lanzetti L. Emerging functions of the EGFR in cancer. Mol Oncol. 2018;12(1):3–20.
   PubMed Web of Science ®Google Scholar
• Cohen MH, Johnson JR, Chen YF, Sridhara R, Pazdur R. FDA drug approval summary: erlotinib (Tarceva®) tablets. Oncologist. 2005;10(7):461–466.
   PubMed Web of Science ®Google Scholar
• Gaber AA, El-Morsy AM, Sherbiny FF, Bayoumi AH, El-Gamal KM, El-Adl K, Al-Karmalawy AA, Ezz Eldin RR, Saleh MA, Abulkhair HS. Pharmacophore-linked pyrazolo[3,4-d]pyrimidines as EGFR-TK inhibitors: synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies. Arch Pharm. 2021:e2100258.
   PubMed Web of Science ®Google Scholar
• Gaber AA, Bayoumi AH, El-Morsy AM, Sherbiny FF, Mehany AB, Eissa IH. Design, synthesis and anticancer evaluation of 1H-pyrazolo [3, 4-d] pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers. Bioorg Chem. 2018;80:375–395.
   PubMed Web of Science ®Google Scholar
• Mowafy S, Galanis A, Doctor ZM, Paranal RM, Lasheen DS, Farag NA, Jänne PA, Abouzid KA. Toward discovery of mutant EGFR inhibitors; design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivatives. Bioorg Med Chem. 2016;24(16):3501–3512.
   PubMed Web of Science ®Google Scholar
• Othman IM, Alamshany ZM, Tashkandi NY, Gad-Elkareem MA, Anwar MM, Nossier ES. New pyrimidine and pyrazole-based compounds as potential EGFR inhibitors: synthesis, anticancer, antimicrobial evaluation and computational studies. Bioorg Chem. 2021;114:105078.
   PubMed Web of Science ®Google Scholar
• Zheng H, Zhang Y, Zhan Y, Liu S, Lu J, Feng J, Wu X, Wen Q, Fan S. Prognostic analysis of patients with mutant and wild-type EGFR gene lung adenocarcinoma. CMAR. 2019;11:6139–6150.
   Google Scholar
• Nakamura JL. The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications. Expert Opin Ther Targets. 2007;11(4):463–472.
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717–13.
   PubMed Web of Science ®Google Scholar
• Elebeedy D, Badawy I, Elmaaty AA, Saleh MM, Kandeil A, Ghanem A, Kutkat O, Alnajjar R, Abd El Maksoud AI, Al-Karmalawy AA. In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus. Comput Biol Med. 2022;141:105149.
   PubMed Web of Science ®Google Scholar
• El-Demerdash A, Al-Karmalawy AA, Abdel-Aziz TM, Elhady SS, Darwish KM, Hassan AHE. Investigating the structure–activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors. RSC Adv. 2021;11(50):31339–31363.
   PubMed Web of Science ®Google Scholar
• El Gizawy HA, Boshra SA, Mostafa A, Mahmoud SH, Ismail MI, Alsfouk AA, Taher AT, Al-Karmalawy AA. Pimenta dioica (L.) Merr. bioactive constituents exert anti-SARS-CoV-2 and anti-inflammatory activities: molecular docking and dynamics, in vitro, and in vivo studies. Molecules. 2021;26(19):5844.
   PubMed Web of Science ®Google Scholar
• Salem MA, Aborehab NM, Al-Karmalawy AA, Fernie AR, Alseekh S, Ezzat SM. Potential valorization of edible nuts by-products: exploring the immune-modulatory and antioxidants effects of selected nut shells extracts in relation to their metabolic profiles. Antioxidants. 2022;11(3):462.
   Web of Science ®Google Scholar
• Hammoud MM, Khattab M, Abdel-Motaal M, Van der Eycken J, Alnajjar R, Abulkhair H, Al-Karmalawy AA. Synthesis, structural characterization, DFT calculations, molecular docking, and molecular dynamics simulations of a novel ferrocene derivative to unravel its potential antitumor activity. J Biomol Struct Dyn . 2022:1–18.
   PubMed Web of Science ®Google Scholar
• Ezz Eldin RR, Saleh MA, Alotaibi MH, Alsuair RK, Alzahrani YA, Alshehri FA, Mohamed AF, Hafez SM, Althoqapy AA, Khirala SK, et al. Ligand-based design and synthesis of N'-Benzylidene-3,4-dimethoxybenzohydrazide derivatives as potential antimicrobial agents; evaluation by in vitro, in vivo, and in silico approaches with SAR studies. J Enzyme Inhib Med Chem. 2022;37(1):1098–1119.
   PubMed Web of Science ®Google Scholar
• Salem MA, El-Shiekh RA, Aborehab NM, Al-Karmalawy AA, Ezzat SM, Alseekh S, Fernie AR. Metabolomics driven analysis of Nigella sativa seeds identifies the impact of roasting on the chemical composition and immunomodulatory activity. Food Chem. 2023;398:133906.
   PubMed Web of Science ®Google Scholar
• Elagawany M, Elmaaty AA, Mostafa A, Abo Shama NM, Santali EY, Elgendy B, Al-Karmalawy AA. Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease. J Enzyme Inhib Med Chem. 2022;37(1):2112–2132.
   PubMed Web of Science ®Google Scholar
• Kutkat O, Moatasim Y, Karmalawy A, Abulkhair AA, Gomaa HS, El-Taweel MR, Abo Shama AN, GabAllah NM, Mahmoud M, Kayali DB, et al. Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies. Sci Rep. 2022;12(1):12920.
   PubMed Web of Science ®Google Scholar
• Bryan MC, Burdick DJ, Chan BK, Chen Y, Clausen S, Dotson J, Eigenbrot C, Elliott R, Hanan EJ, Heald R, et al. Pyridones as highly selective, noncovalent inhibitors of T790M double mutants of EGFR. ACS Med Chem Lett. 2016;7(1):100–104.
   PubMed Web of Science ®Google Scholar
• Zaki AA, Ashour A, Elhady SS, Darwish KM, Al-Karmalawy AA. Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: molecular docking, molecular dynamics, and SAR studies. J Tradit Complement Med. 2022;12(1):16–34.
   PubMedGoogle Scholar
• Soltan MA, Eldeen MA, Elbassiouny N, Mohamed I, El-Damasy DA, Fayad E, Abu Ali OA, Raafat N, Eid RA, Al-Karmalawy AA. Proteome based approach defines candidates for designing a multitope vaccine against the nipah virus. Int J Mol Sci. 2021;22(17):9330.
   PubMed Web of Science ®Google Scholar
• Soltan MA, Elbassiouny N, Gamal H, Elkaeed EB, Eid RA, Eldeen MA, Al-Karmalawy AA. In silico prediction of a multitope vaccine against Moraxella catarrhalis: reverse vaccinology and immunoinformatics. Vaccines. 2021;9(6):669.
   Web of Science ®Google Scholar
• Shoala T, Al-Karmalawy AA, Germoush MO, ALshamrani SM, Abdein MA, Awad NS. Nanobiotechnological approaches to enhance potato resistance against potato leafroll virus (PLRV) using glycyrrhizic acid ammonium salt and salicylic acid nanoparticles. Horticulturae. 2021;7(10):402.
   Web of Science ®Google Scholar
• Raslan MA, F. Taher R, Al-Karmalawy AA, El-Ebeedy D, Metwaly AG, Elkateeb NM, Ghanem A, Elghaish RA, Abd El Maksoud AI. Cordyline fruticosa (L.) A. Chev. leaves: isolation, HPLC/MS profiling and evaluation of nephroprotective and hepatoprotective activities supported by molecular docking. New J Chem. 2021;45(47):22216–22233.
   Web of Science ®Google Scholar
• Mahmoud DB, Ismail WM, Moatasim Y, Kutkat O, ElMeshad AN, Ezzat SM, El Deeb KS, El-Fishawy AM, Gomaa MR, Kandeil A, et al. Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: In silico and in vitro studies. J Drug Deliv Sci Technol . 2021;66:102845.
   PubMed Web of Science ®Google Scholar
• Mahmoud DB, Bakr MM, Al-Karmalawy AA, Moatasim Y, El Taweel A, Mostafa A. Scrutinizing the feasibility of nonionic surfactants to form isotropic bicelles of curcumin: a potential antiviral candidate against COVID-19. AAPS PharmSciTech. 2021;23(1):44.
   PubMed Web of Science ®Google Scholar
• Mahmoud A, Mostafa A, Al-Karmalawy AA, Zidan A, Abulkhair HS, Mahmoud SH, Shehata M, Elhefnawi MM, Ali MA. Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies. Heliyon. 2021;7(9):e07962.
   PubMed Web of Science ®Google Scholar
• Mahmoud A, Kotb E, Alqosaibi AI, Al-Karmalawy AA, Al-Dhuayan IS, Alabkari H. In vitro and in silico characterization of alkaline serine protease from Bacillus subtilis D9 recovered from Saudi Arabia. Heliyon. 2021;7(10):e08148.
   PubMedGoogle Scholar
• Ma C, Taghour MS, Belal A, Mehany ABM, Mostafa N, Nabeeh A, Eissa IH, Al-Karmalawy AA. Design and synthesis of new quinoxaline derivatives as potential histone deacetylase inhibitors targeting hepatocellular carcinoma: in silico. Front Chem. 2021;9:725135–725135.
   PubMed Web of Science ®Google Scholar
• Khattab M, Al-Karmalawy AA. Computational repurposing of benzimidazole anthelmintic drugs as potential colchicine binding site inhibitors. Future Med Chem. 2021;13(19):1623–1638.
   PubMed Web of Science ®Google Scholar
• Hamed MI, Darwish A, Soltane KM, Chrouda R, Mostafa A, Abo Shama A, Elhady NM, Abulkhair SS, Khodir HS, Elmaaty AE, et al. β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico, in vitro, and SAR studies for lead optimization. RSC Adv. 2021;11(56):35536–35558.
   PubMed Web of Science ®Google Scholar
• Al-Karmalawy AA, Farid MM, Mostafa A, Ragheb AY, Mahmoud SH, Shehata M, Shama NMA, GabAllah M, Mostafa-Hedeab G, Marzouk MM. Naturally available flavonoid aglycones as potential antiviral drug candidates against SARS-CoV-2. Molecules. 2021;26(21):6559.
   PubMed Web of Science ®Google Scholar
• Abdallah AE, Alesawy MS, Eissa SI, El-Fakharany EM, Kalaba MH, Sharaf MH, Abo Shama NM, Mahmoud SH, Mostafa A, Al-Karmalawy AA, et al. Design and synthesis of new 4-(2-nitrophenoxy)benzamide derivatives as potential antiviral agents: molecular modeling and in vitro antiviral screening. New J Chem. 2021;45(36):16557–16571.
   Web of Science ®Google Scholar
• Abo Elmaaty A, Hamed MIA, Ismail MI, Elkaeed EB, Abulkhair HS, Khattab M, Al-Karmalawy AA. Computational insights on the potential of some NSAIDs for treating COVID-19: priority set and lead optimization. Molecules. 2021;26(12):3772.
   PubMed Web of Science ®Google Scholar
• Belal A, Abdel Gawad NM, Mehany ABM, Abourehab MAS, Elkady H, Al-Karmalawy AA, Ismael AS. Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1, 4]diazepine derivatives as potent EGFR/CDK2 inhibitors. J Enzyme Inhib Med Chem. 2022;37(1):1884–1902.
   PubMedGoogle Scholar
• Attia EZ, Khalifa BA, Shaban GM, Amin MN, Akil L, Khadra I, Karmalawy AAA, Alnajjar R, Zaki MYW, Aly OM, et al. Potential topoisomerases inhibitors from Asergillus terreus using virtual screening. S Afr J Bot . 2022;149:632–645.
   Web of Science ®Google Scholar
• Hammouda MM, Elmaaty AA, Nafie MS, Abdel-Motaal M, Mohamed NS, Tantawy MA, Belal A, Alnajjar R, Eldehna WM, Al-Karmalawy A, et al. Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: in vitro, in vivo, molecular docking, molecular dynamics, and SAR studies. Bioorg Chem. 2022;127:105995.
   PubMed Web of Science ®Google Scholar
• Khattab M, Al-Karmalawy AA. Revisiting activity of some nocodazole analogues as a potential anticancer drugs using molecular docking and DFT calculations. Front Chem. 2021;9:628398.
   PubMed Web of Science ®Google Scholar
• Elebeedy D, Elkhatib WF, Kandeil A, Ghanem A, Kutkat O, Alnajjar R, Saleh MA, Abd El Maksoud AI, Badawy I, Al-Karmalawy AA. Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights. RSC Adv. 2021;11(47):29267–29286.
   PubMed Web of Science ®Google Scholar